Thanks very much.
I think we get it: you don't think this is working.
If we are going to design a system that works, I guess one of our concerns after hearing from the cancer folks is that if you end up with every single disease having a separate system, this is going to be pretty difficult. And there's the fact that rare diseases clump themselves together, and obviously diabetes is hugely common.
I would like you to tell me what you think a system that worked would look like. I worry when we're trying to go constructively forward that if we say that people die, and you can't tell who has died, then we lose ground. If you say that people are dying in the streets, we actually lose credibility on this file. If we pull out numbers like 2%, in the sense that we want 2% assigned for rare diseases, then people ask, where did you get that from?
We know that in the national pharmaceutical strategy there is a view to getting to a national formulary and having the best possible people come together to make these decisions. Can you describe what you would prefer and how we would get the provinces and territories and the five federal formularies to come together to actually do something that would work?